Navigation Links
Women Health Expert GC-Rise Listed in Deloitte's 50 Top-performing Companies
Date:12/5/2011

BEIJING, Dec. 5, 2011 /PRNewswire-Asia/ -- GC-Rise Pharmaceutical Co. Ltd, in which European healthcare venture capital firm INVENTAGES holds a majority stake, was recently listed as one of the Deloitte & Touche's 50 top-performing Chinese high-tech companies which rides on high growth over the past three years.

Beijing-headquartered GC-Rise, which focuses on women's health in China, saw its operating revenues rising more than 270% on average per annum from 2008 to 2010 thanks to a strong market demand in China.

An awards ceremony was held in Shenzhen, a boom city in southern China's Guangdong province. GC-Rise's founder & chief executive officer Wren Zhang presented the company's growth model.

"GC-Rise, mainly engages in sales of women's health-care products, and benefits from a business model via buying exclusive distribution rights of products developed by overseas producers, then selling them to hospitals or drugstores with the trademark of GC-Rise registered in China," Zhang said.

Eying China's huge potential market, GC-Rise attracted financial investors at the very outset. Zhang said that GC-rise had completed the first round of financing worth US$5 million in 2008 and a further US$8 million in second round in 2010.

The enrollment in the top 50 by Deloitte shows that GC-Rise's focus on the women's niche market has borne fruit, with growth momentum gathering pace despite the repercussions of the financial crisis since 2008.  

About Deloitte & Touche's top 50

The rating of the top 50 Chinese companies initiated by Deloitte & Touche, which focuses on high-tech, media and telecom industries, are based on core criteria of annual operating revenues growth rate over the past three years rather than assets expansion. Those enrolled in the list are qualified to contend for top 500 in Asia Pacific.

About GC-Rise Pharmaceutical Co. Ltd

GC-Rise Pharmaceutical Co. Ltd, established in 2008, is a wholly-owned foreign enterprise invested by INVENTAGES, a major European healthcare and biotechnology venture capital investor, focused on women's health. Taking "Devoted to human healthcare and a better life" as our mission, the company makes full use of the business networks of our strategic partners in the United States, Europe and Japan, their rich experiences in clinical development, clinical trials and registration in China and their strong strength in distributions, hospital sales and marketing, so as to provide safe, novel and highly efficient medical products and treatment ideas for Chinese women patients.

Please log on http://www.gc-rise.com/ to know more information.


'/>"/>
SOURCE GC-Rise Pharmaceutical Co. Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Growth Hormone Increases Bone Formation in Obese Women
2. Americas State of Mind: New Report Finds Americans Increasingly Turn to Medications to Ease their Mental Woes; Women Lead the Trend
3. Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000
4. Simbionix to Introduce Three New Womens Health Products
5. Merz Aesthetics and Inspirational Women Join Forces to Recognize Women Who STAND AND DELIVER
6. Philips Enters North American Mammography Market, Underscoring its Global Commitment to Womens Health Care
7. Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Womens Health Technologies at the Journees Francaises de Radiologie (JFR)
8. Joy & Eve Behar Launch Bilingual Heart Health Guide Inspired By Women Heart Attack Survivors and Caregivers
9. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
10. Healthcare Businesswomens Association (HBA) Hosts Panel Discussion in Washington DC on Digital Health
11. Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery , one of this ... A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said the round was intended ...
(Date:2/11/2016)... CARLSBAD, Calif. , Feb.11, 2016  Ionis Pharmaceuticals, Inc. ... a live webcast on Thursday, February 25 at 11:30 a.m. ... on pipeline and business progress. www.ionispharma.com . ... at the same address. --> www.ionispharma.com . A ... the same address. --> Interested parties may listen ...
(Date:2/11/2016)... -- Indiso ltd , a medical technology company ... respiratory diseases announced today positive results in its clinical ... patients show improvements in respiratory functions and other clinical ... Upper and lower respiratory tract diseases and allergy ... reached epidemic level. Increasing number of studies however show ...
Breaking Medicine Technology:
(Date:2/11/2016)... DC (PRWEB) , ... February 11, 2016 , ... ... an upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for ... not-for-profit Catholic health care system that’s partnering with Intel on value-based health benefits ...
(Date:2/11/2016)... ... February 11, 2016 , ... veEDIS Clinical Systems, ... with highly adaptable algorithms, has been updated to help Emergency Department physicians and ... consistent with Zikas and a travel history to affected regions, or potential exposure ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... call for nominations seeking candidates for the Board of Commissioners. Individuals interested in ... skills and experience with diversity of clinical practice settings and across allied health ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back from ... poses a question as a challenge for his readers to examine the full ... Being" (published by Partridge Singapore), Clarke explores the subject with more depth, revealing ...
(Date:2/11/2016)... ... 11, 2016 , ... PharmMD CEO Robert Yeager ... focus on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will ... in data breaches for the Part D Star Rating improvement and Medication Therapy ...
Breaking Medicine News(10 mins):